CHECKPOINT INHIBITOR TREATMENT BEFORE HAPLOIDENTICAL...

HemaSphere 2019 / 06 Vol. 3

CHECKPOINT INHIBITOR TREATMENT BEFORE HAPLOIDENTICAL TRANSPLATATION IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA (HL) PATIENTS IS ASSOCIATED WITH HIGHER PFS WITHOUT INCREASED TOXICITIES

De Philippis, C., Legrande, F., Bramanti, S., de Oca, Montes C., Dulery, R., Bouabdallah, R., Granada, A., Devillier, R., Mariotti, J., Sarina, B., Harbi, S., Maisano, V., Furst, S., Pagliardini, T.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000563244.72263.27
Date:
June, 2019
File:
PDF, 299 KB
2019
Conversion to is in progress
Conversion to is failed